This inventor holds 26 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Chemokine Receptor Modulators. Top assignees: Imperial Chemical Industries Limited, Astrazeneca Ab, Zeneca Limited. Active years: 1978-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Macclesfield, EN (1978)
- Cheshire, GB (2006 - 2008)
- Macclesfield, GB (1980 - 2009)
Company Filing History:
12 out of 3,840 
8 out of 1,534 
6 out of 854 
Years Active: 1978-2009
Areas of Expertise:
Title: Howard Tucker: Innovator in Pharmaceutical Patents
Introduction
Howard Tucker, a prominent inventor located in Macclesfield, GB, has made significant contributions to the field of pharmaceuticals, with a remarkable portfolio of 26 patents. His innovative work focuses on developing novel compounds and processes aimed at advancing medical therapies.
Latest Patents
One of Howard Tucker's latest patents involves piperidine derivatives as modulators of the chemokine receptor CCR5. This patent, which details compounds of formula (I), encompasses compositions that include these compounds, processes for their preparation, and their applications in medical therapy, specifically aimed at modulating CCR5 receptor activity in warm-blooded animals.
Another significant patent granted to Tucker covers arylpiperazines as metalloproteinase inhibiting agents. This invention features arylpiperazines of formula (I) that serve as inhibitors, particularly focusing on MMP-13, demonstrating his expertise in creating valuable pharmaceutical agents.
Career Highlights
Throughout his career, Howard Tucker has been associated with respected companies such as Imperial Chemical Industries Limited and AstraZeneca AB. His work in these leading institutions has enabled him to advance his research and development endeavors, solidifying his role as a crucial innovator in the pharmaceutical sector.
Collaborations
In addition to his achievements, Tucker has collaborated with notable professionals in the industry including John Oldfield and Peter Warner. These partnerships have contributed to the successful development of his patented inventions and the advancement of pharmaceutical research.
Conclusion
With 26 patents to his name, Howard Tucker continues to lead innovative efforts in the pharmaceutical field, particularly focusing on compounds that have the potential to revolutionize therapeutic practices. His contributions through extensive research and collaborations mark him as a notable figure in the realm of medical inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile